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Highlights 
 We introduce the HIrisPlex-S system for eye, hair, and skin colour prediction from DNA
 HIrisPlex-S consists of a novel 17-plex and the previous 24-plex HIrisPlex assay
 In forensic validation testing, the 17-plex performed similarly to the 24-plex assay
 HIrisPlex-S consists of three prediction models for eye, hair, and skin colour
 https://hirisplex.erasmusmc.nl/ provides eye, hair, skin colour probabilities from genotypes
Abstract 
Forensic DNA Phenotyping (FDP), i.e. the prediction of human externally visible traits from DNA, has 
become a fast growing subfield within forensic genetics due to the intelligence information it can provide 
from DNA traces. FDP outcomes can help focus police investigations in search of unknown perpetrators, 
who are generally unidentifiable with standard DNA profiling. Therefore, we previously developed and 
forensically validated the IrisPlex DNA test system for eye colour prediction and the HIrisPlex system for 
combined eye and hair colour prediction from DNA traces. Here we introduce and forensically validate 
the HIrisPlex-S DNA test system (S for skin) for the simultaneous prediction of eye, hair, and skin colour 
from trace DNA. This FDP system consists of two SNaPshot-based multiplex assays targeting a total of 
41 SNPs via a novel multiplex assay for 17 skin colour predictive SNPs and the previous HIrisPlex assay 
for 24 eye and hair colour predictive SNPs, 19 of which also contribute to skin colour prediction. The 
HIrisPlex-S system further comprises three statistical prediction models, the previously developed 
IrisPlex model for eye colour prediction based on 6 SNPs, the previous HIrisPlex model for hair colour 
prediction based on 22 SNPs, and the recently introduced HIrisPlex-S model for skin colour prediction 
based on 36 SNPs. In the forensic developmental validation testing, the novel 17-plex assay performed in 
full agreement with the Scientific Working Group on DNA Analysis Methods (SWGDAM) guidelines, as 
previously shown for the 24-plex assay. Sensitivity testing of the 17-plex assay revealed complete SNP 
profiles from as little as 63 pg of input DNA, equalling the previously demonstrated sensitivity threshold 
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of the 24-plex HIrisPlex assay. Testing of simulated forensic casework samples such as blood, semen, 
saliva stains, of inhibited DNA samples, of low quantity touch (trace) DNA samples, and of artificially 
degraded DNA samples as well as concordance testing, demonstrated the robustness, efficiency, and 
forensic suitability of the new 17-plex assay, as previously shown for the 24-plex assay. Finally, we 
provide an update of the publically available HIrisPlex website https://hirisplex.erasmusmc.nl/, now 
allowing the estimation of individual probabilities for 3 eye, 4 hair, and 5 skin colour categories from 
HIrisPlex-S input genotypes. The HIrisPlex-S DNA test represents the first forensically validated tool for 
skin colour prediction, and reflects the first forensically validated tool for simultaneous eye, hair and skin 
colour prediction from DNA. 
 
Keywords: HIrisPlex-S; eye colour; hair colour; skin colour; Forensic DNA phenotyping; forensic 
developmental validation, predictive DNA analysis 
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Introduction 
When standard forensic DNA analysis based on short tandem repeats (STRs), or other types of 
polymorphic DNA markers such as single nucleotide polymorphisms (SNPs), fails to identify the donor 
of a human biological trace found at a crime-scene via comparative DNA profiling, i.e. no match with any 
known suspect or DNA database hit is obtained, alternative approaches are needed. Such DNA-based 
investigative intelligence can aid police by providing physical appearance information of the unknown 
trace donor from evidence DNA, which may help locating unknown perpetrators by allowing focused 
police investigation. Forensic DNA Phenotyping (FDP), used as a collective term for such DNA 
intelligence approaches, includes the prediction of externally visible characteristics (EVC’s) from forensic 
DNA traces [1-3]. In its wider context, FDP additionally comprises the genetic inference of bio-
geographic ancestry and the estimation of epigenetic age from DNA. FDP is also useful for describing a 
person’s physical appearance from skeletal remains using DNA [4-6], such as those that deal with missing 
person cases or mass disaster victim identification (DVI) scenarios, especially in cases where ante-
mortem samples and known relatives are unavailable in the early phase of investigation. The latter is 
additionally relevant outside the forensic realm in fields such as anthropology and evolutionary biology, 
to reconstruct physical appearance information for the remains of persons from the recent or distant past, 
including the field of palaeogenetics [4, 6, 7]. 
Over the last 10 years, candidate gene association studies and genome-wide association studies 
(GWASs), as well as subsequent prediction analyses, have established various EVC-predictive SNPs and 
prediction models, most notably for human pigmentation traits [8-30]. In particular, the prediction of 
broad (i.e., categorical) eye and hair colour phenotypes from SNP genotypes is now achievable with 
practically useful accuracies, for instance by applying the IrisPlex and HIrisPlex DNA test systems that 
have been forensically validated [31-34], as well as tested and applied [35, 36]. Similar tools for eye and 
hair colour DNA prediction that largely overlap in SNP predictors with the Iris/HIrisPlex systems have 
also been generated and used [21, 37-42]. This advancement in understanding the genetic basis and DNA-
based predictability of eye and hair colour was achievable in part because these two pigmentation traits 
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evolved in genetically homogeneous Europeans that were used in these genetic studies, and therefore are 
found today almost exclusively in people of (at least partial) European bio-geographic ancestry. In 
general, the success of genetic association studies depend on the genetic homogeneity of the study 
population used, such as people from ‘within’ continental regions. However, with its global variation 
maximized between continental groups, this is largely different for skin colour. Thus, genetic association 
studies on skin colour, either genome-wide or candidate gene focused studies could only be performed 
within continental groups such as Europeans and South Asians [10, 12, 14, 17, 26, 27, 30, 43] In 
consequence, the delivered genetic knowledge is less complete than that achievable for eye and hair 
colour.  
Therefore, the predictability of skin colour from DNA [37-39] lagged behind that of eye and hair 
colour [30-42]. Valenzuela et al. [21] obtained a low R2 value for skin reflectance of 45.7% based on 
three SNPs. Spichenok et al. [38] applied 7 SNPs for predicting not-white, not-dark and not-white / not-
dark skin colour. However, the general limitation of using no-colour categories when attempting to 
predict colour, the authors were unable to obtain prediction outcomes in 28% of their samples [38], which 
could not be improved considerably in a subsequent study  [37]. Pospiech et al.[44] used 17-18 SNPs and 
achieved a prediction accuracy expressed as area under the receiver operating characteristics curve (AUC) 
of 0.67 for light versus dark skin colour (AUC of 0.5 represents random prediction and 1.0 completely 
accurate prediction). Liu et al. [26] presented 9 SNPs suitable for predicting skin colour variation in 
Europeans and people from nearby regions, but not in Asians, Native Americans and Subs-Saharan 
Africans, which is explained by their identification via GWAS in Europeans. In 2014, Maronas et al. [25] 
published the first comprehensive study investigating the skin colour predictive value of 59 candidate 
pigmentation SNPs using three skin colour categories; white, intermediate and black. In this study, a 
subset of 10 of the most skin colour predictive SNPs from 8 genes was highlighted and high AUC values 
of 0.999 for White, 0.996 for Black and 0.803 for Intermediate skin colour were reported [25]. However, 
general problems of all of these previous skin colour prediction studies are the rather small sample size 
used, leading to limited reliability of the reported prediction accuracy estimates.  
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Aiming to improve the reliability of skin colour prediction by using an increased number of 
global individuals as well as the level of detail of DNA-based skin colour prediction by increasing the 
number of predicted categories, we recently assessed 77 pigmentation SNPs from 37 genetic loci in 2025 
globally dispersed human individuals [29]. From this dataset, we developed a novel prediction model for 
5 skin colour categories based on 36 SNPs from 16 genes, which achieved AUC values of 0.75 for Very 
Pale, 0.73 for Pale, 0.75 for Intermediate, 0.84 for Dark, and 0.98 for Dark-Black skin colour [29]. As 
shown previously via direct comparison in 194 individuals from 17 different populations not involved in 
prediction model training or assessment [29], this new model outperformed the previously proposed 
model [25].  
With the present study, we provide the necessary genotyping and phenotype prediction tools 
needed for implementing the recently established skin colour predictive DNA markers and prediction 
model [29] into Forensic DNA Phenotyping practice and other applications. We combined skin colour 
prediction from DNA with the previously established eye and hair colour prediction tools [31-34] into a 
single DNA test system, the HIrisPlex-S (S for skin) system. For this, we developed a novel multiplex 
genotyping assay for 17 skin colour prediction SNPs and performed forensic developmental validation 
according to the SWGDAM guidelines [45], as we previously did for the HIrisPlex assay, which targets 
24 eye and hair colour predicting SNPs [34] of which 19 also contribute to skin colour prediction. Besides 
these two multiplex genotyping assays, the HIrisPlex-S system additionally consists of three statistical 
prediction models, the previous IrisPlex model for eye colour prediction [19, 31, 32, 34], the previous 
HIrisPlex model for hair colour prediction [33, 34], and the recently established HIrisPlex-S model for 
skin colour prediction [29]. Finally, we provide an easy-to-use web interface at 
https://hirisplex.erasmusmc.nl/ allowing the retrieval of individual prediction probabilities for 3 eye 
colour, 4 hair colour, and now 5 skin colour categories from HIrisPlex-S genotype input data of 41 SNPs.   
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Materials and methods 
A selection of body fluid and tissue samples were collected in-house from individuals with informed 
consent including single and multiple source samples and simulated casework samples (saliva, blood, 
semen, vaginal swabs and touched items). DNA was extracted from all the samples using the QIAamp 
DNA Mini kit (Qiagen, Hagen, Germany) according to the manufacturer’s guidelines, or an in-house 
standard salting out protocol (unpublished). All the extracted DNA samples were quantified using the 
Quantifiler Human DNA Quantification kit (Applied Biosystems Inc., Foster City, USA) following the 
manufacturer’s guidelines. 
 
Multiplex design and genotyping protocol 
A set of 36 SNPs from 16 genes were chosen as the final set of SNP predictors for skin colour based on 
our recent work published elsewhere [29], which include 19 of the 24 of the SNPs included in the 
previously developed HIrisPlex assay [33, 34] that we left unchanged in the design of the HIrisPlex-S 
system. The newly developed second genotyping assay of the HIrisPlex-S system includes 17 SNPs from 
7 genes: ANKRD11 rs3114908, OCA2 rs1800414, BNC2 rs10756819, HERC2 rs2238289, SLC24A4 
rs17128291, HERC2 rs6497292, HERC2 rs1129038, HERC2 rs1667394, TYR rs1126809, OCA2 
rs1470608, SLC24A5 rs1426654, ASIP rs6119471, OCA2 rs1545397, RALY rs6059655, OCA2 
rs12441727, MC1R rs3212355, and DEF8 rs8051733. Primer3Plus, a publically available web-based 
design software, was used to design the 17 primer pairs and their respective single base extension (SBE) 
primers, using the default parameters of the software program [46]. For each SNP, both forward and 
reverse SBE primers were designed and tested, and the most suitable of the two was finally included in 
the multiplex system. To ensure complete capillary electrophoresis separation between the 17 SBE 
products, poly-T tails of differing lengths were added to the 5’ end of the SBE primers (Table 1). In order 
to cater for degraded samples, the PCR fragments were designed to be short as much possible and PCR 
fragment sizes were limited to less than 150 bp if possible (the largest fragment is 170 bp). Prior to lab 
testing, all the primer sequences were analysed using AutoDimer software program [47] to avoid primer-
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primer interactions. All the marker details, primer sequences and primer concentrations are provided in 
Table 1. PCR amplification of all 17 SNPs was performed in a single multiplex PCR assay in a total 
volume of 10 μl, containing PCR primers in specified concentrations, 1 μl genomic DNA extract (varying 
concentrations), 1X PCR buffer (Applied Biosystems), 2.5 mM MgCl2 (Applied Biosystems), 220 μM of 
each dNTP (Roche, Mannheim, Germany) and 1.75 U AmpliTaq Gold DNA polymerase (Applied 
Biosystems). A GeneAmp PCR System thermocycler (Applied Biosystems) was used for all 
amplifications, with the following parameters: 95oC for 10 minutes, 33 cycles of 95oC for 30 seconds and 
62oC for 30 seconds, 62oC for 5 minutes. The amplified PCR products were purified with ExoProStar – S 
(GE Healthcare Europe GmbH, Eindhoven, The Netherlands) and incubated at 37oC for 45 minutes and 
80oC for 15 minutes. SBE was carried out for all 17 PCR products simultaneously in a single multiplex 
reaction using 2 μl of the purified PCR product and 1 μl of the SNaPshot Ready Reaction Mix with the 
following thermocycler parameters: 96oC for 2 minutes; 25 cycles of 96oC for 10 seconds, 50oC for 5 
seconds, 60oC for 30 seconds. The extended products were then purified using 1 μl of shrimp alkaline 
phosphatase (SAP) (USB Corporation) and incubated at 37oC for 45 minutes and 75oC for 15 minutes. 
Finally, the purified SBE products were analysed on the ABI 3130xl Genetic Analyser (Applied 
Biosystems) with POP-7 polymer on a 36 cm capillary length under an injection voltage of 2.5kV for 10 
seconds and with a running time of 500 seconds at 60oC. Gene Mapper v3.7 software program (Applied 
Biosystems) was used for the allele calling and analysis of the results. 
 
Sensitivity testing and optimization for peak height balance  
The sensitivity of the new 17-plex assay was evaluated to determine the minimum concentration of input 
DNA needed to achieve complete SNP profiles. For this, DNA from three individuals were diluted and 
quantified in duplicate with the Quantifiler Human DNA Quantification kit (Applied Biosystems) 
following the manufacturer’s guidelines at 500 pg, 250 pg, 125 pg, 63 pg and 32 pg, and finally 
genotyped. A threshold of 50 relative fluorescence units (RFU) was used to call the allele peaks. In 
addition, an assessment of homozygote and heterozygote average peak heights of the 17-plex from 20 
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replicates at 250 pg DNA input using 10 different individuals was performed and standard errors of the 
means were calculated. 
 
Mixture studies and reproducibility testing 
DNA samples from two individuals of known genotype at genomic DNA concentration of 500 pg were 
mixed in the ratios of 1:1, 1:5 and 1:10. DNA mixtures were used to assess the ability of the novel 17-
plex to detect DNA mixtures. Reproducibility or concordance testing was performed on 30 samples of 
varying DNA concentrations, SNP genotypes, and eye, hair, and skin colour phenotypes by five 
independent laboratories, four of which had no previous experience with the HIrisPlex-S assay. The five 
laboratories involved in the concordance testing were i) the Forensic Laboratory for DNA Research 
(FLDO) at the Leiden University Medical Centre (LUMC), ii) the research group of the Division 
Biological Traces at the Netherlands Forensic Institute (NFI), iii) the Malopolska Centre of 
Biotechnology of the Jagiellonian University in Poland, iv) the Department of Biology at the Indiana 
University Purdue University Indianapolis (IUPUI) in the USA, and v) the Department of Genetic 
Identification at Erasmus MC University Medical Center Rotterdam in the Netherlands. The latter 
laboratory who developed the assay with equal input from IUPUI, provided the other four laboratories 
with DNA samples, reagents, a written protocol, genotypes of the HIrisPlex assay, and an Excel macro for 
the statistical prediction of eye, hair and skin colour. Depending on the laboratory, SBE fragments were 
separated and genotyped on an ABI 3100 machine using POP-4, and an ABI 3130xl (or ABI 3500) 
machine using POP-7 polymer. Results were analysed using GeneMarker (Soft Genetics) or GeneMapper 
v4.0 (Applied Biosystems) software. 
 
Species specificity, stability testing and simulated case sample analysis 
The species origin of samples collected at a crime-scene often is unknown and they may represent 
contamination from different biological sources. Hence, a variety of non-human species was genotyped 
with the novel 17-plex assay to assess its human amplification specificity. Commercially available DNA 
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samples of chicken, cat, mouse, pig, bovine, rat, and dog DNA at 3 ng input and a chimpanzee sample of 
1 ng input were used. DNA was obtained commercially from Novagen, Inc. (Madison, WI) for all but the 
chimpanzee sample, which was described elsewhere [48]. Human biological material collected at the 
crime scene can contain degraded DNA. To test for the influence of degraded DNA on the 
performance of the novel 17-plex, DNA from an individual with a concentration of 250 pg was 
exposed to ultraviolet light at intervals of 0 seconds, 30 seconds, 60 seconds, 5 minutes, 10 
minutes, 15 minutes, 20 minutes and 30 minutes using a Bio-Link (Vilber Lourmat) at a strength 
of 50 J/cm2 and genotyped. We genotyped simulated casework samples that included fresh 
blood, dried blood, semen, vaginal swab, saliva, nasal mucus, samples with PCR inhibitor 
haematin, DNA mixtures and trace DNA of low quality and quantity with the novel 17-plex 
assay as well as the 24-plex HIrisPlex assay and under a blind proficiency testing conditions 
(Supplementary Table 2). All these samples were PCR-quantified using the Quantifiler Human 
DNA Quantification kit (Applied Biosystems) as per the manufacturer’s guidelines. 
 
Population studies 
The novel 17-plex assay was used to genotype the HGDP-CEPH H952 [49] sample set from 51 global 
populations after removal of sample duplications and related samples. Due to DNA shortage, 762 HGDP-
CEPH individuals were finally used for skin colour prediction using the recently established prediction 
model [29] in combination with the genotypes from the 24-plex HIrisPlex assay established previously 
for these samples [33]. The MapViewer 7 (Golden Software, Inc., Golden, CO, USA) package was used 
to plot the genotype distributions of the 17 SNPs on the world map, respectively. In addition, we used 
these HGDP-CEPH genotype data to generate a global skin colour prediction map available with the 
HIrisPlex-S DNA test system. In order to fill in geographic gaps for global skin colour prediction using 
the HirisPlex-S model and the HGDP-CEPH set described above, 36 skin colour specific SNPs were 
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downloaded from 777 individuals from 8 populations (IBS, FIN, ACB, CLM, GBR, KHV, PEL, PUR) of 
the 1000 genomes project [50] and included in the global skin colour prediction map.  
 
Categorical pigmentation prediction models 
The human skin colour prediction model used here has been recently described elsewhere [29]. Briefly, 
the skin colour categories as part of this prediction model are based on a dermatological established 
Fitzpatrick scale for skin colour and sun sensitivity. A dermatologist reviewed skin colour imagery and a 
questionnaire about the participants ability to tan, this led to the definition of a Fitzpatrick scale 
assignment, which was then converted to a specific skin colour category for this skin colour prediction 
model as follows: Fitzpatrick Scale I=Very Pale skin colour, II=Pale, combined III & IV = Intermediate, 
V=Dark, VI=Dark to Black. This skin colour model completes the HIrisPlex-S system, which is now 
capable of predicting eye colour using the IrisPlex model coefficients [19, 31, 32, 34], hair colour using 
the HIrisPlex model coefficients [33, 34] and skin colour using the HIrisPlex-S model coefficients [29]. 
This skin colour prediction tool, together with the previously released eye and hair colour prediction 
tools, are made publicly available via an easy-to-use web interface at https://hirisplex.erasmusmc.nl/. 
Moreover, , there have been additions in the numbers of individuals used in the eye and hair colour 
prediction models with this publication, which explains potential slight differences in the eye and hair 
colour probabilities outputs relative to the previously enhanced eye and hair colour prediction models 
available via the HIrisPlex website as previously described by Walsh et al. [34]. In particular, 278 
individuals for eye colour and 277 for hair colour were additionally included from a US-based population 
set containing individuals whose parental place of birth was outside the US in the following countries 
(Nigeria, Mexico, Columbia, India, Bangladesh, Palestine, Canada, China, Honduras, Germany, 
Philippines, Russia, Sudan, Japan, Saudi Arabia, Pakistan, El Salvador, Spain, Haiti, South Korea, 
Vietnam). These individuals are also included in the skin colour prediction model. Thus, as of August 
2017, the model validation datasets underlying the individual probabilities available from this website 
consists of 9466 individuals for eye colour, 1878 individuals for hair colour, and 1423 individuals for skin 
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colour. When the model input alleles are generated from the two multiplex genotyping assays and entered 
into the HIrisPlex-S prediction tool, individual probabilities for 3 eye colour, 4 hair colour, and 5 skin 
colour categories are generated from the underlying eye, hair, and skin colour prediction models, 
respectively. Interpretation rules for eye colour based on the category with the highest probability value as 
well as hair colour based on a prediction guide have been previously published [31-34], while the 
interpretation of skin colour is described here (see below).  
 
 
Results and Discussion 
Multiplex design, sensitivity testing and peak height balance studies 
As presented here, the HIrisPlex–S system includes two genotyping assays based on the principle of 
multiplex PCR followed by multiplex single-base primer extension (SBE) using SNaPshot chemistry: a 
novel 17-plex assay described here and the previously developed and described 24-plex HIrisPlex assay 
[33, 34] that remained unchanged in the HIrisPlex-S system. All together the two multiplex assays target 
41 eye and/or hair and/or skin colour-predicting SNPs. For skin colour prediction on a 5-category level 
(Very Pale, Pale, Intermediate, Dark and Dark-Black), the HIrisPlex-S system considers all 36 SNPs 
recently highlighted as suitable predictors of categorical skin colour [29], of which 19 overlap with those 
targeted with the 24-plex HIrisPlex assay: MC1R rs1805007, MC1R rs1805008, MC1R rs11547464, 
MC1R rs885479, MC1R rs228479, MC1R rs1805006, MC1R rs1110400, IRF4 rs12203592, OCA2 
rs1800407, SLC45A2 rs16891982, SLC45A2 rs28777, HERC2 rs12913832, TYR rs1042602, TYR 
rs1393350, PIGU rs2378249, LOC105370627 (formerly SLC24A4) rs12896399, SLC24A4 rs2402130, 
TYRP1 rs683, and KITLG rs12821256. The remaining 17 SNPs targeted with the newly developed second 
multiplex assay are ANKRD11 rs3114908, BNC2 rs10756819, SLC24A4 rs17128291, HERC2 rs2238289, 
HERC2 rs6497292, HERC2 rs1129038, HERC2 rs1667394, TYR rs1126809, OCA2 rs1470608, OCA2 
rs1800414, OCA2 rs12441727, OCA2 rs1545397, SLC24A5 rs1426654, ASIP rs6119471, RALY 
rs6059655, MC1R rs3212355, and DEF8 rs8051733.   
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PCR amplicon size of approximately 170 bp or less (ideally 150 bp) were achieved for almost all 
of the SNPs in the novel 17-SNP assay (Table 1), akin to those in the previous 24-plex HIrisPlex assay 
[34], allowing application to degraded DNA typically found in forensic samples. Both the PCR, and SBE 
multiplexes were optimized to achieve the optimal balanced 17-SNP genotype profile, to ensure accurate 
results being obtained across all the SNPs in a wide range of samples with different DNA quantities and 
qualities. Despite these efforts, the peak height of one SNP (ASIP rs6059655) was lower compared to the 
other 16 SNPs in this multiplex assay, which makes this DNA marker a candidate for dropout in case of 
low quantity or quality DNA being analysed. It is workable, however, in cases where allelic dropouts are 
suspected in a DNA sample analysed, that this SNP is genotyped by singleplex PCR/SBE.  
To test for the sensitivity of the novel 17-plex assay, DNA samples from three individuals with 
different skin colour categories, hence different SNP alleles, were serially diluted and PCR-quantified 
input DNA amounts of 500 pg, 250 pg, 125 pg, 63 pg and 32 pg were genotyped. Individual 1 displayed 
phenotypic dark skin colour, individual 2 displayed phenotypic intermediate skin colour, and individual 3 
displayed phenotypic pale skin colour. As seen in Figure 1, it was possible to obtain full 17-SNP profiles 
down to 63 pg input DNA, while with 32 pg locus or allele drop-outs were seen in all three individuals 
tested. In particular, individual 1 showed locus or allele dropouts at 6 SNPs: ANKRD11 rs3114908 (allele 
T from the heterozygous CT), BNC2 rs10756819 (allele G from the heterozygous GA), HERC2 
rs6497292 (heterozygous CT), HERC2 rs1667394 (allele C of heterozygous CT), OCA2 rs1470608  
(heterozygous CA) and RALY rs6059655 (homozygous genotype  CC). Individual 2 presents dropouts at 5 
SNPs BNC2 rs10756819 (allele G of heterozygous GA), OCA2 rs1470608 (heterozygous genotype CA), 
SLC24A5 rs1426654 (homozygous AA), OCA2 rs12441727 (heterozygous genotype GA), and DEF8 
rs8051733 (heterozygous genotype CT). Individual 3 reflects dropouts at 3 SNPs: HERC2 rs1129038 
(homozygous AA), TYR rs1126809 (allele A of heterozygous genotype GA), and RALY rs6059655 
(homozygous CC). As expected, with a decrease in starting DNA amount, increased heterozygote peak 
imbalance was observed. Notably, the sensitivity threshold of the novel 17-plex assay obtained at 63 pg 
input DNA equals that of the 24-plex HIrisPlex assay as established previously [34]. 
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An important aspect in assay design is to assess balance between the peak heights (RFUs) of 
homozygote and heterozygote alleles. Figure 2 illustrates the average peak height ranges observed in 
homozygote and heterozygote genotypes at 250 pg of input DNA across 10 different individuals of 
various skin colours and thus different SNP alleles from 20 replicate analyses for each individual DNA 
samples (Ntotal =200 profiles). As evident, we obtained reasonably good balance (peak heights are similar 
or within 10% of each other) of the homozygote stages of both alleles for most of the 17 SNPs (Figure 
2A) with the exception of four SNPs i.e., OCA2 rs18004141, HERC2 rs6497292, OCA2 rs1545397, and 
OCA2 rs12441727. For 5 SNPs, it was not possible to display the average peak heights for the T/T 
homozygote allele of ANKRD11 rs3114908 and RALY rs6059655, respectively, the C/C homozygote 
allele of SLC24A4 rs17128291 and ASIP rs6119471, respectively, as well as the A/A homozygote allele 
of TYR rs1126809 and MC1R rs3212355, respectively, because these homozygote genotypes were not 
represented in the test set used (consequently these alleles are absent from Figure 2A). We also observed 
good peak height balance for the heterozygote allele stages for most of these 17 SNPs, with the exception 
of BNC2 rs10756819, TYR 1126809, and OCA2 rs12441727 (Figure 2B). For two SNPs, i.e., OCA2 
rs1800414 and MC1R rs3212355 the heterozygote genotypes were absent from the test set used here (and 
are therefore absent from Figure 2B). We expect that at least some of the allelic peak height imbalances 
seen are influenced by differences in intensity levels of the four fluorescence dyes used to label the four 
bases in the primer extension reaction of the SNaPshot chemistry, which cannot be avoidable unless 
moving away from fluorescence-based SNP-typing technologies. In the near future, it is believed that 
targeted massively parallel sequencing (MPS) designs [51] will start to replace single base extension 
assays using the SNaPshot chemistry; however this will mean that all forensic laboratories would require 
a bench-top sequencer, which may take some years to occur. For the results on the developmental 
validation of the 24-plex HIrisPlex assay, see Walsh et al. [34]. 
 
DNA mixture studies 
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DNA from two individuals carrying different pigmentation phenotypes and thus different SNP genotypes, 
at a DNA input level of 500 pg were mixed in the ratios of 1:1, 1:5 and 1:10 and genotyped with the 17-
plex (for respective results of the HIrisPlex assay, see [34]). Individual 1 reported a phenotype of brown 
eye, black hair and dark skin colour, while individual 2 reported blue eyes, blond hair and pale skin 
colour. These two individuals differ at 6 of the 17 SNPs, for 5 of them this refers to heterozygote in one 
and homozygote in the other samples, while for one SNP the two alleles are seen in opposite homozygote 
states in these two individuals (Figure 3). In the 1:1 mixture, there appears to be peak balance (no obvious 
allelic height discrepancies, similar in peak height) in several of the 17 SNPs except at HERC2 rs1129038 
(SNP7 in Figure 3 when counting from the left), HERC2 rs1667394 (SNP8), OCA2 rs1545397 (SNP 13) 
and DEF8 rs8051733 (SNP17). Nevertheless, it is difficult to deduce if the profile at a mixture ratio of 1:1 
is a true mixture, or a single source sample with heterozygous alleles. However, at mixture ratios of 1:5, 
and more so at 1:10, dropouts and peak imbalances increased at BNC2 rs10756819 (SNP 3), HERC2 
rs2238289 (SNP4) and HERC2 rs6497292 (SNP6), HERC2 rs1129038 (SNP7), HERC2 rs1667394 
(SNP8) and OCA2 rs1545397 (SNP13). In general, peak height imbalance could indicate a probable 
presence of mixtures, however, a dropout may not be considered true unless it was compared to a single 
sample profile. Moreover, as with eye and hair colour and using the Iris/HIrisPlex system, also for skin 
colour using the HIrisPlex-S system, there is a considerable chance that individuals who contribute to a 
DNA mixture have overlapping SNP alleles, especially if they share the same pigmentation phenotypes, 
which makes DNA mixtures difficult if not impossible to detect from such data. This, however, reflects 
the general disadvantage in mixture deconvolution when using autosomal SNPs, and is not a specific 
problem of SNP assays of the Iris/HIris/HIrisPlex–S systems. It is to be noted, however, that in routine 
forensic casework, STR profiling is typically performed prior to FDP analysis and allows detecting if a 
DNA mixture is present or not. STR profiling currently is the method of choice for mixture detection and 
deconvolution [52], and can be improved when massively parallel sequencing technologies are applied for 
STR analysis. 
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Reproducibility studies  
Concordance testing is required to assess the implementation of a new genotyping assay in a laboratory, 
and is particularly informative when involving those without previous experience with the assay being 
tested. Apart from the laboratories at Erasmus MC and IUPUI involved in developing the novel 17-plex, 
the other 3 laboratories included in this concordance testing had no previous experience with this 
genotyping assay at the time. However, all laboratories had previous experience with the 24-plex 
HIrisPlex assay. Only the novel 17-plex assay was tested in this concordance study, as the HIrisPlex 
assay had already been forensically validated before, including concordance testing [34].  
Of the total of 30 DNA samples with varying DNA concentrations distributed for concordance 
testing (see Supplementary Table 1), 25 (83.3%) were genotyped correctly at all 17 SNPs. Of the 5 
samples for which discordant genotypes were observed, 4 samples had genotyping errors at 1 or 2 SNPs, 
respectively. One sample had dropouts or errors in 4 of the 5 laboratories involved (Supplementary Table 
1). However; with 48 pg, this sample had the lowest input DNA amount of all 30 samples used in the 
concordance testing, and was the only one in this sample set that was below the established sensitivity 
threshold of 63 pg (see above), which explains the insufficient results. Lab 3 produced erroneous results 
in 4 samples, lab 2 in two samples, and lab 4 as well as lab 5 in one sample, respectively.  
To test for concordance not only regarding genotype generation but also phenotype prediction, 
the 24-plex HIrisPlex genotypes were provided to the participating laboratories, as was access to the eye, 
hair, and skin colour prediction models for probability estimation. Eye, hair, and skin colour prediction 
probabilities were established correctly in 28 of the 30 samples (93.3%) by all the labs. Lab 3 could not 
establish the correct prediction probabilities in sample 5 (110 pg), and 4 laboratories had issues with 
determining the pigmentation phenotypes of sample 26, which was the one with the lowest DNA input of 
48 pg and was below the established sensitivity threshold (Supplementary Table 1). In such 
circumstances, reporting of the predictions generated from low input DNA typing (below the set 
threshold, in this case 63 pg), should include a clause that the prediction will be impacted by possible 
missing alleles due to potential allelic drop/out. 
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Specificity studies  
A variety of animal species were tested with the novel 17-plex assay to assess its human specificity, as 
done previously for the 24-plex HIrisPlex assay [34]. Supplementary Figure 1 depicts the peaks observed 
above the 50 relative fluorescent units threshold in each of the non-human species at 3 ng and for the 
chimpanzee sample at 1 ng. Not unexpected given the evolutionary relationship between chimpanzees and 
humans, 14 out of 17 SNPs revealed allelic signals in the chimp sample. In contrast, almost no peaks were 
called in all other, evolutionary more distant species tested such as dog, cat, rat, mouse, pig, bovine and 
chicken. The only exceptions were one peak called in chicken and one in bovine (plus off-size peaks that 
were therefore not called: 1 in chicken, 1 in rat, and 2 in dogs, see Supplementary Figure 1). Therefore, 
with the exception of closely related non-human primates, this study provides good evidence for the 
human specificity of genotypes obtained with the novel 17-plex assay. However, it should be kept in 
mind that FDP is typically performed subsequent to standard DNA profiling and observing forensic STR 
profiles provides sufficiently reliable evidence on the human source of the DNA used.  
 
Degradation and simulated casework studies 
In order to test the ability of the 17-plex assay to deal with degraded DNA, that is often confronted with 
in forensic DNA analysis, aliquots of the same single source DNA sample at an input of 250 pg was 
subjected to artificial degradation by exposing to ultraviolet light at varying time intervals of 0 seconds, 
30 seconds, 1 minute, 5 minutes, 10 minutes, 20 minutes, and 30 minutes. These DNA samples were then 
genotyped with the novel 17-plex assay. Full 17-SNP profiles were obtained from all degraded DNA 
samples receiving ultraviolet light exposure for up to 10 minutes. After 20 minutes of UV light exposure, 
allele dropouts were observed at two SNPs, OCA2 rs1470608 and BNC2 rs10756819. These results 
indicate the robustness of the assay to deal with DNA degradation, at least to the level generated with 
these experiments, where larger fragments (such as those used in commercial STR kits) would more than 
likely drop out. 
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To test for the ability of the complete HIrisPlex-S system to produce reliable genotypes as well as 
reliably predicted pigmentation phenotypes from different forensically relevant biological materials, 25 
simulated casework samples from blood, semen, saliva, touch DNA, mixtures as well as high and low 
concentrations of haematin inhibited samples were genotyped with both multiplex assays; the novel 17-
plex assay and the 24-plex HIrisPlex assay. All these samples were blind-tested and the details are 
presented in Supplementary Table 2. Of the 19 single source samples used here, 17 (90%) were correctly 
genotyped and correctly phenotyped for all three pigmentation traits, even though several included low 
peak heights due to low amounts of input DNA, and two specifically below the established sensitivity 
threshold of 63 pg. The two single source samples where no genotypes and thus no phenotypes could not 
be established represent a (touch) DNA sample and a strongly inhibited sample containing high 
concentrations of haematin, which both showed many allelic dropouts. Of the 6 mixture samples, five 
were correctly identified as DNA mixtures due to noticeable peak imbalance; however, phenotype 
prediction was not possible in these samples because of impossible mixture deconvolution. The one 
mixture sample not correctly identified as DNA mixture was a low quantity touch DNA sample from 
multiple sources; because it was incorrectly interpreted as a single source, the phenotype interpretation 
was incorrect too. Thus, the HIrisPlex-S system was effective in producing reliable results across different 
mock samples representing different casework type scenarios with varying input concentrations, 
particularly for single source samples.  
 
Population studies, global SNP distributions and global skin colour prediction 
The novel 17-plex assay was applied to the HGDP-CEPH H952 sample set (n=952) by excluding 190 
individuals due to DNA shortage, leaving 762 individuals in the analysis. Each of the 17 SNP’s global 
allelic frequency distribution is shown in Supplementary Figure 2, demonstrating various degrees of 
global variation. As may be expected for SNPs associated with and predictive for skin colour, a trait with 
strong continental differentiation, several of these 17 SNPs provide a relatively strong differentiation 
between different continental regions. Most evident were European versus Non-European differentiation 
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for SLC24A5 rs1426654 (Supplementary Figure 2K) and HERC2 rs1129038 (Supplementary Figure 2G), 
Asian versus non-Asian differentiation for MC1R rs3212355 (Supplementary Figure 2P), OCA2 
rs1545397 (Supplementary Figure 2M), and OCA2 rs1800414 (Supplementary Figure 2B); and African 
versus non-African differentiation for ASIP rs6119471 (Supplementary Figure 2L), HERC2 rs6497292 
(Supplementary Figure 2F), HERC2 rs1667395 (Supplementary Figure 2H), OCA2 rs12441727 
(Supplementary Figure 2O), and BNC2 rs10756819 (Supplementary Figure 2C). For information 
regarding continental differentiation of the 19 skin colour predicting SNPs that are part of the HIrisPlex 
assay (and thus not shown here), see supplementary figure S2-S4 of Walsh et al. [33].  
Figure 4 depicts the prediction of the five skin-colour categories; Very Pale, Pale, Intermediate, 
Dark and Dark-Black on a global scale, as achieved with the HIrisPlex-S system using the results of the 
novel 17-plex genotyped generated here together with the previously generated 24-plex HIrisPlex 
genotypes [34], and applying the global skin colour prediction model published recently [29]. For this, we 
used the HGDP-CEPH set and 8 additional population samples from the 1000 Genomes Project [50] 
(IBS, FIN, ACB, CLM, GBR, KHV, PEL, PUR) selected to fill gaps in the global areas represented by 
the HGDP set as much as possible. In this analysis, no threshold parameters were used and the category 
with the highest probability value was used to conclude the predicted skin colour category for illustration 
purpose (but see the next section for more details). As evident from Figure 4, global skin colour 
prediction achieved with the HIrisPlex-S system agrees with the overall expectation of global skin colour 
distribution. Although skin colour phenotypes are not directly available for the individuals analysed, they 
can be broadly assumed from general knowledge of global skin colour distribution. For instance, Sub-
Saharan Africans are known to typically have very dark skin colour, which is also the case for most (but 
not all) New Guineans. Indeed, we exclusively predicted Dark-Black in the HGDP-CEPH Sub-Saharan 
Africans, which is the darkest skin colour category in the prediction model, as well as in HGDP-CEPH 
New Guineans (except for a single individual predicted Dark). Europeans are known to have very pale, 
pale, and intermediate skin colour. Indeed, we predicted these 3 skin colour categories in the HGDP-
CEPH Europeans, in addition to Dark in Southern Europeans from Sardinia, which can be true. Very Pale 
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is predicted rarely in these Europeans, which is explained by the limited number of North and North-
Western populations used. Asians are known to vary highly in skin colour across the region with the 
exception of very pale skin; indeed, we predicted Pale, Intermediate, Dark, and Dark-Black skin colour in 
HGDP-CEPH East and South Asians. To note, the HGDP-CEPH samples from Senegal (n=21), Nigeria 
(n=21), Kenya (n=11), and Papua New Guinea, (n=17) were previously used in the development of the 
skin colour prediction model [29]; hence, predictions in these populations are not completely 
independent, as is true for all other population samples included here. In any case, additional population 
testing using global DNA samples for which skin colour phenotypic information is available is very likely 
to support the global prediction patterns presented here. Moreover, newly identified skin colour 
associated SNPs should also be assessed for their contribution to global skin colour prediction models in 
future studies, such as those recently identified by Tishkof et al. [53] and Martin et al. [54]. 
 
The prediction models for eye, hair, and skin colour of the HIrisPlex-S system 
The addition of the recently established skin colour predictive SNPs and skin colour prediction model 
[29] to the previously established HIrisPlex system for eye and hair colour prediction [34], therefore now 
named HIrisPlex-S system, completes the categorical prediction of human pigmentation traits from DNA. 
Consequently, we have updated the publically available HIrisPlex website https://hirisplex.erasmusmc.nl/ 
now additionally providing access to the skin colour prediction model in addition to the eye and hair 
colour prediction models available previously. Thus, this website now provides individual probabilities 
for 3 eye colour, 4 hair colour, and 5 skin colour categories from HIrisPlex-S input genotypes of 41 SNPs. 
Note that in addition to adding skin colour prediction to the website, we also enhanced the eye and hair 
colour prediction models by including more individuals in the model-underlying reference datasets, 
respectively (see details provided in the Material and Methods section).  
An illustrative example of the skin colour prediction results obtained with the HIrisPlex-S system 
is shown in Figure 5 for a subset of 35 individuals originating from 8 American, European, African and 
Asian countries (USA, Ireland, China, Mexico, Nigeria, Rwanda, India, El Salvador), Notably, these 
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individuals were not previously used for building or validating the skin colour prediction model. In this 
figure, the individual skin photographs were ordered according to the outcomes of the HIrisPlex-S system 
i.e., with increase in the highest prediction probabilities from the top left hand corner to the bottom right 
hand corner and in the skin colour direction of Very Pale to Dark-Black. Skin colour phenotypes were not 
considered in the ordering. As evident, there is a high correlation between the visual representation of the 
skin colour phenotypes in the skin photographs and the highest DNA-predicted skin colour category in 
these example individuals used for illustration purposes only.  
 
Skin colour prediction interpretation 
To acknowledge the complex nature of skin colour and its global variation predictable with the 
HIrisPlex-S system, we recommend that the final conclusion on the most likely skin colour from the 
HIrisPlex-S genotypes is obtained from the predicted skin colour category with the highest probability 
value with influence from the second highest probability value as generated by the HIrisPlex-S model. 
Depending on its strength, the second highest probability category can influence the detected skin colour 
together with the highest probability category. Two examples are shown in Figure 6, and also outlined in 
the tool manual available at https://hirisplex.erasmusmc.nl/. In example 1, although Pale is the predicted 
skin colour category with the highest probability in both of these individuals with almost identical 
probability values (0.588 and 0.582, respectively), in A) the Very Pale category is second high (0.389) 
whereas in B) it is the Intermediate category (0.398) with very similar probabilities. From this one can 
conclude that individual A is unlikely to darken / tan with sun exposure in summer months, whereas 
individual B likely will. It can thus be expected individual B to have slightly darker skin colour at least 
after sun exposure than individual A, as visible from the photographs. Consequently, although both 
individuals have almost the same highest probability for Pale, the finally concluded skin colour prediction 
for individual B shall be Pale to Intermediate, whereas for individual A it is Pale to Very Pale. Likewise, 
individuals C and D have the very same high probability for Dark (0.693) as highest probability value, in 
C the second highest probability (0.299) is for Intermediate whereas in D it is for Dark-Black (0.301) with 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 22 
almost the same value. Consequently, although both individuals have the same highest probability for 
Dark, the final skin colour conclusion for individual C shall be Dark to Intermediate, whereas for 
individual D it is Dark to Dark-to-Black. Further investigation into the precise threshold at which each 
category will impact on the major (highest) category prediction should be performed in more samples 
than available here. However, in Table 2 we provide a preliminary skin colour prediction guide with the 
current threshold levels. Lastly, as the topic of likelihood ratio (LR) versus probability with relation to the 
interpretation of Forensic DNA Phenotyping model outcomes has been debated, explanations on the 
preferred use of probabilities instead of likelihood ratios with regard to the DNA prediction of EVCs have 
been provided recently by Caliebe et al. [55] 
 
Conclusions 
We hereby introduce and forensically validate the HIrisPlex-S DNA test system capable of 
simultaneously predicting categorical eye, hair and skin colour phenotypes from DNA, which consists of 
two multiplex genotyping assays and three statistical prediction models for eye, hair and skin colour 
respectively. A novel multiplex assay targeting 17 skin colour predictive SNPs was developed and 
forensically validated as an addition to the previously developed and validated HIrisPlex assay targeting 
24 eye and hair colour predictive SNPs, of which 19 are additionally used for skin colour prediction. The 
forensic developmental validation of the novel 17-plex system fulfils SWGDAM guidelines in terms of 
sensitivity, stability, mixtures and simulated casework sample studies [45] as previously shown for the 
24-plex HIrisPlex assay [34]. Most notably, the HIrisPlex-S system is capable of generating full 41-SNP 
profiles from a minimum input DNA quantity of 63 pg, reflecting the sensitivity threshold for obtaining 
full profiles with both multiplex assays. The newly developed 17-plex assay is capable of coping with 
degraded DNA samples due to the PCR fragment sizes of less than 150 bp and as proven experimentally 
in preliminary DNA degradation testing, and as was previously established also for the 24-plex HIrisPlex 
assay [34]. Finally, we updated the HIrisPlex website https://hirisplex.erasmusmc.nl/ by making available 
the skin colour model in addition to the eye and hair colour model available previously so that upload of 
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genotypes from all 41 SNPs of the HIrisPlex-S system allows generating individual probabilities for 3 eye 
colour, 4 hair colour and 5 skin colour categories. Overall, the results of the forensic developmental 
validation performed here and previously [34] demonstrate the robustness and reliability of the HIrisPlex-
S genotyping assay and may encourage its use for the prediction of all three human pigmentation traits 
from DNA in criminal cases, missing person cases, and outside the forensic arena such as those in 
anthropological or evolutionary applications to bringing back eye, hair and skin colour of deceased 
persons from analysing their skeletal remains. In the future, the identification of additional skin colour 
DNA predictors and their addition to the DNA prediction system would be appreciated, particularly to 
improve the prediction accuracies of the three ‘white’ categories Very Pale, Pale, and Intermediate that 
with the current model are predicted with considerably lower accuracy than the Dark and Dark-Black skin 
colour categories [29]. Moreover, in the long run, a move towards a quantitative prediction output for skin 
colour, as well as for eye and hair colour, is the preferred direction of further research and development. 
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Figures Legend 
Figure 1: Sensitivity testing with the 17-plex assay of the HIrisPlex-S DNA test system. DNA samples 
from three individuals with different skin colour phenotypes and different SNP genotypes ranging from 1 
ng to 32 pg DNA input were used. Individual 1 displayed phenotypic dark skin colour, individual 2 
displayed phenotypic intermediate skin colour, and individual 3 displayed phenotypic pale skin colour. 
The sensitivity threshold was established at 63 pg, which equals that previously obtained for the 24-plex 
HIrisPlex assay. Allele dropouts highlighted by black circles were observed at 32pg in all three 
individuals, but not at any higher input DNA concentrations. 
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Figure 2: Homozygote and heterozygote testing with the 17-plex assay of the HIrisPlex-S DNA test 
system. Average peak height obtained from 20 replicates for each of the 10 test individuals using 250 pg 
of DNA input in the HIrisPlex-S assay are shown. Samples were run with an ABI 3130xl Genetic 
Analyser, using POP-7 on a 36 cm capillary length array. The T/T homozygote allele of rs3114908 
(SNP1), and rs6059655 (SNP14), the C/C homozygote allele of rs17128291 (SNP5) and rs6119471 
(SNP12), and the A/A homozygote allele from rs1126809 (SNP9) and rs3212355 (SNP16) are absent 
from 2(A) and the heterozygote SNP profile of  ra1800414 (SNP2) and rs3212355 (SNP16) are absent in 
2(B). Error bars represent 95% standard error of the averages. The number at the bottom of each of the 
bars in 2(A) and 2(B) indicates the number of individuals in which the respective allele(s) was observed 
in the 10 test individuals. 
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Figure 3: Mixture analysis with the 17-plex assay of the HIrisPlex-S DNA test system. We used 1:1, 1:5 
and 1:10 mixtures from DNA samples of two individuals with different skin colour phenotypes and 
different HIrisPlex-S genotypes, individual 1 had phenotypic dark skin colour, and individual 2 had 
phenotypic pale skin colour. DNA used was approximately 500 pg per individual. The asterisks represent 
peak height imbalance indicative of possible DNA mixture.  
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Figure 4: Global skin colour prediction with the HIrisPlex-S DNA test system. In total, 1539 individuals 
from 59 global populations were used, that were 762 samples from 51 populations of the HGDP-CEPH 
panel, and additional data from 777 individuals from 8 populations of the 1000 Genomes Project (IBS, 
FIN, ACB, CLM, GBR, KHV, PEL, PUR) were selected to fill geographic gaps as much as possible. 
Each individual is predicted to be one of five skin-colour categories; Very Pale, Pale, Intermediate, Dark 
and Dark-Black, with the highest probability used as finally predicted skin colour category. The 
MapViewer 7 (Golden Software, Inc., Golden, CO, USA) package was used to plot this distribution. 
Europe, Israel, Pakistan, China & Mongolia were enlarged to give a better view of the skin colour 
predictions observed in populations from those regions. The size of the pie charts represented the number 
of individuals analysed in the respective population sample. 
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Figure 5: Illustrative example of the performance of the skin colour prediction model provided with the 
HIrisPlex-S DNA test system. In total, 35 individuals from 8 different countries (USA, Ireland, China, 
Mexico, Nigeria, Rwanda, India, El Salvador) were used. The individual skin images were ordered 
according to the increase in the highest prediction probabilities of the respective skin colour categories 
from the top left hand corner to the bottom right hand corner and in the skin colour direction from Very 
Pale to Dark-Black. Image ordering was completely independent from skin colour phenotypes. These 
individuals were not used for building and validating the HIrisPlex-S skin colour prediction model. 
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Figure 6: Illustrative examples of the influence the second highest probability category has together with 
the highest probability category on skin colour prediction provided with the HIrisPlex-S DNA test 
system. Example 1 highlights the effect of the second highest probability (Very Pale (A) or Intermediate 
(B)) influencing the highest probability Pale prediction for those two individuals. Example 2 highlights 
the effect of the second highest probability (Intermediate (C) or Dark-Black (D)) influencing the highest 
probability Dark prediction for those two individuals. We recommend (see Table 2) taking the highest 
together with the second highest probability category into account for finally concluding the most likely 
categorical skin colour with the HIrisPlex-S DNA test system. 
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Tables 
Table 1. The novel 17-plex assay from the HIrisPlex-S DNA test system with PCR and SBE primer sequences and concentration. 
As
sa
y 
Po
siti
on 
PCR 
Prim
ers 
B
as
es Sequence 
Conc
entra
tion Product Size 
SBE 
Prim
ers 
Ge
ne 
NC
BI 
dir
ect
ion 
H
PS 
m
o
de
l 
in
p
ut 
B
as
es Sequence 
Conc
entra
tion 
1 
rs311
4908
_F 
2
0 
CAGAACACAGC
CACACCCTA 
0.4 
µm 118bp 
rs311
4908
_R 
AN
KR
D1
1  Rev 
C/
T 
2
9 
TTTTTTTTTTAGAGAAGGGTCAAGCACT
T 
0.12 
µm 
  
rs311
4908
_R 
2
0 
CATAAAGGGG
TCACCAGCAA 
0.4 
µm                 
                          
2 
rs180
0414
_F 
2
0 
GCTGCAGGAG
TCAGAAGGTT 
0.4 
µm 145bp 
rs180
0414
_R 
OC
A2 Rev 
T/
C 
4
3 
TTT TTT TTT TTC AGA ATC CCG TCA 
GAT ATC CTA 
0.2 
µm 
  
rs180
0414
_R 
2
0 
GGGACAAACG
AATTGAGGAA 
0.4 
µm                 
                          
3 
rs107
5681
9_F 
2
0 
AAAGCAAGCTC
ATGTTTCCA 
0.4 
µm 145bp 
rs107
5681
9_F 
BN
C2 
Fw
d 
A/
G 
3
5 
TTTTTTTTTTTTGGACCAGTTATTTTGGG
TTTGGA 
1.7 
µm 
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rs107
5681
9_R 
2
3 
CGTCATGACTA
GAAAAACACCA
A 
0.4 
µm                 
                          
4 
rs223
8289
_F 
2
1 
GGAACATGAA
GATTTCCCAGT 
0.4 
µm 112bp 
rs223
8289
_F 
HE
RC2 Rev 
C/
T 
5
3 
TTT TTT TTT TTT TTT TTT TTG AGA 
TTG GAA GAT TGG AGC C 
0.5 
µm 
  
rs223
8289
_R 
2
2 
CTGATTCAGGT
CTGCTGTCACT 
0.4 
µm                 
                          
5 
rs171
2829
1_F 
2
0 
CCAGCACTGCC
AAAATAACA 
0.4 
µm 129bp 
rs171
2829
1_R 
SLC
24
A4 
Fw
d 
T/
C 
5
8 
TTT TTT TTT TTT TTT TTT TTT CAA TGT 
GCA CTG GAT TAA AAG TC 1 µm 
  
rs171
2829
1_R 
2
0 
CTCTTTGGACC
CATCACCTC 
0.4 
µm                 
                          
6 
rs649
7292
_F 
2
1 
TCTGCTGTAGA
ACCAATGTCC 
0.4 
µm 150bp 
rs649
7292
_R 
HE
RC2 
Fw
d 
T/
C 
6
1 
TTT TTT TTT TTT TTT TTT TTT TTT TTG 
TCT CCT GTG TCT TCA TCC T 
0.2 
µm 
  
rs649
7292
_R 
2
1 
GAATTGCACCT
GTAGCTCCAT 
0.4 
µm                 
                          
7 
rs112
9038
_F 
2
0 
ATGTCGACTCC
TTTGCTTCG 
0.4 
µm 137bp 
rs112
9038
_F 
HE
RC2 Rev 
A/
G 
7
0 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT GAG CCA GGC AGC AGA 
GC 
0.4 
µm 
  
rs112
9038
_R 
2
0 
ACACCAGGCAG
CCTACAGTC 
0.4 
µm                 
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8 
rs166
7394
_F 
2
4 
CAGCTGTAGAG
AGAGACTTTGA
GG 
0.4 
µm 130bp 
rs166
7394
_R 
HE
RC2 Rev 
C/
T 
7
3 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT GCA GCA ATT CAA AAC GTG 
CAT A 
0.2 
µm 
  
rs166
7394
_R 
2
0 
CACCATTAAGA
CGCAGCAAT 
0.4 
µm                 
                          
9 
rs112
6809
_F 
2
7 
TGTTTCTTAGTC
TGAATAACCTT
TTCC 
0.4 
µm 100bp 
rs112
6809
_F TYR 
Fw
d 
A/
G 
7
7 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TGT ATT TTT GAG CAG 
TGG CTC C 
0.05 
µm 
  
rs112
6809
_R 
2
0 
GGTGCATTGGC
TTCTGGATA 
0.4 
µm                 
                          
10 
rs147
0608
_F 
2
6 
TTTCTTGTGTTA
ACTGTCCTTAC
AAA 
0.4 
µm 145bp 
rs147
0608
_F 
OC
A2 Rev 
A/
C 
6
2 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTC ATT CTC TCT TAA AAA TAT 
TAA TTT GCA CC 4 µm 
  
rs147
0608
_R 
2
3 
GGAAAATATGT
TAGGGTTGATG
G 
0.4 
µm                 
                          
11 
rs142
6654
_F 
2
0 
TTCAGCCCTTG
GATTGTCTC 
0.4 
µm 123bp 
rs142
6654
_F 
SLC
24
A5 
Fw
d 
A/
G 
8
6 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT TGT CTC 
AGG ATG TTG CAG GC 
0.16 
µm 
  
rs142
6654
_R 
2
6 
TGAGTAAGCAA
GAAGTATAAG
GAGCA 
0.4 
µm                 
                          
12 
rs611
9471
_F 
2
0 
GCAGGAGAAT
TGCTGGAACT 
0.4 
µm 170bp 
rs611
9471
_R 
ASI
P 
Fw
d 
G/
C* 
9
1 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT TGA AGG 
AAG AGT GAA AAT GCG TAA 1 µm 
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rs611
9471
_R 
2
1 
AACCCGAAGG
AAGAGTGAAA
A 
0.4 
µm                 
                          
13 
rs154
5397
_F 
2
4 
GGTATAGGATT
ATTTGGGGAAT
GA 
0.4 
µm 144bp 
rs154
5397
_F 
OC
A2 
Fw
d 
A/
T 
9
7 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT GTA CAA CTT 
TGT GAA TAT ACT AAA ATA C 1 µm 
  
rs154
5397
_R 
2
8 
TGGAGATATAG
AATTCACACAA
CATAAA 
0.4 
µm                 
                          
14 
rs605
9655
_F 
2
0 
GTGAGGAAAT
CGAGGCTCAG 
0.4 
µm 112bp 
rs605
9655
_R 
RAL
Y 
Fw
d 
A/
G 
7
6 
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTGC
TGATGCCCTGAGCA 2 µm 
  
rs605
9655
_R 
2
0 
AGGAGAAAGC
TGCAGATCCA 
0.4 
µm                 
                          
15 
rs124
4172
7_F 
2
0 
GGGAAGAGAC
AGCTCCATGT 
0.4 
µm 137bp 
rs124
4172
7_F 
OC
A2 
Fw
d 
A/
G 
1
0
6 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TGG CTC AGT GTG GCC 
TT 
0.5 
µm 
  
rs124
4172
7_R 
2
0 
ACAATCCTGGG
AGGTACACG 
0.4 
µm                 
                          
16 
rs321
2355
_F 
2
0 
GAGTGAACCCA
GGAAGATGC 
0.4 
µm 144bp 
rs321
2355
_R 
MC
1R 
Fw
d 
T/
C 
1
1
3 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TCC GAA GCC 
CAG CAG G 
1.5 
µm 
  
rs321
2355
_R 
2
0 
CATCAAAGGCA
GACCTCTCG 
0.4 
µm                 
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17 
rs805
1733
_F 
1
9 
AGGCGGTGGT
CTCTCTCTC 
0.4 
µm 124bp 
rs805
1733
_R 
DEF
8 
Fw
d 
T/
C 
1
1
5 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTC ACC CTG CCT 
GTC TCG 
1.6 
µm 
  
rs805
1733
_R 
2
0 
TTGCAACAGGA
GGGTCTAGG 
0.4 
µm                 
             
 
*When using the HPS assay, the minor allele to add is C if present, but when using sequencing data that uses NCBI forward design and forward 
primer, you must flip strand of your sequence result before inputting the C allele if present 
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Table 2. Preliminary prediction guide for the interpretation of skin colour probability values and thresholds obtained with the HIrisPlex-S DNA 
test system. 
 
  
 
Very Pale     
If highest 
probability 
> 0.9p Very Pale predicted   
      
If highest 
probability 
> 0.7p 
Very Pale is predicted however it will be affected by the second highest category if it is > 
0.15 p and will appear darker   
  Very Pale is predicted, unlikely to be affected by the second highest category if it is < 0.15 p   
      
If highest 
probability 
> 0.5p 
Prediction significantly affected by second category, and will be a mix of the two highest 
categories (tends to represent the darker second highest category)   
      
  Pale     
 
  
 
If highest 
probability 
> 0.9p Pale predicted   
      
If highest 
probability 
> 0.7p 
Pale is predicted however it will be affected by the second highest category if it is > 0.15 p  
(will appear darker if Intermediate, and lighter if pale)   
  Pale is predicted, unlikely to be affected by the second highest category if it is < 0.15 p   
      
If highest 
probability 
> 0.5p 
Prediction significantly affected by second category, and will be a mix of the two highest 
categories (tends to represent the darker second highest category)   
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  Not significantly impacted if second highest prediction is Very Pale   
      
  Int.     
 
  
 
If highest 
probability 
> 0.9p 
Intermediate predicted (*unless Dark-Black is the second highest category, then prediction is 
Dark)   
      
If highest 
probability 
> 0.7p 
Intermediate is predicted however it will be affected by the second highest category if it is > 
0.15 p  (will appear darker if Dark/Dark-Black and lighter if Very Pale/Pale)   
  
Intermediate is predicted, unlikely to be affected by the second highest category if it is < 
0.15 p  (*unless it is Dark-Black, then prediction is Dark)   
      
If highest 
probability 
> 0.5p 
Prediction significantly affected by second category, and will be a mix of the two highest 
categories (darker if Dark/Dark-Black represents the second highest category)   
  Not significantly impacted if second highest prediction is Very Pale/Pale    
      
  Dark     
 
  
 
If highest 
probability 
> 0.9p Dark predicted   
      
If highest 
probability 
> 0.7p 
Dark is predicted, unlikely to be affected by the second highest category if it is > 0.15 p 
(*unless it is Dark-Black, then prediction can be Dark-Black)   
  
Dark is predicted, unlikely to be affected by the second highest category if it is < 0.15 p 
(*unless it is Dark-Black, then prediction can be Dark-Black)   
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If highest 
probability 
> 0.5p 
Prediction significantly affected by second category, and will be a mix of the two highest 
categories (dark to black if Dark-Black represents the second highest category)   
  Not significantly impacted if second highest prediction is Pale/Intermediate   
      
  
Dark-
Black     
 
  
 
If highest 
probability 
> 0.9p Dark to Black predicted   
      
If highest 
probability 
> 0.7p 
Dark to Black is predicted, unlikely to be affected by the second highest category if it is > 
0.15 p   
  
Dark to Black is predicted, unlikely to be affected by the second highest category if it is < 
0.15 p   
      
If highest 
probability 
> 0.5p 
Prediction affected by second category, and will be a mix of the two highest categories (Will 
be lighter than Dark to Black if Dark represents the second highest category)   
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